| It is currently Tue May 21, 2013 4:29 am |
|
All times are UTC - 8 hours [ DST ] |
|
Page 1 of 1 |
[ 2 posts ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| squiffy2 |
|
|||||
Joined: Wed Oct 14, 2009 3:00 pm Posts: 1684 |
|
|||||
| Top | |
|||||
| ssmme |
|
|||||
Joined: Sat Sep 22, 2007 3:00 pm Posts: 344 Location: Lexington, KY |
|
|||||
| Top | |
|||||
|
Page 1 of 1 |
[ 2 posts ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
| Novel fumarate analog XP23829 for RRMS begins phase I trial | 0 | 343 | Mon Jul 23, 2012 11:48 pm | ||
| A new era of Multiple Sclerosis therapies begins | 0 | 780 | Thu Jul 15, 2010 12:31 am | ||
| Major MS study begins in Scotland | 1 | 652 | Sat Jun 18, 2011 10:02 am | ||
| DACLIZUMAB | 22 | 3968 | Thu Jun 08, 2006 5:01 am | ||
| New international research collaborative begins work | 0 | 258 | Tue Aug 28, 2012 8:47 am | ||
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |